Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Applied Therapeutics Inc.

    NASDAQ: APLT · Real-Time Price · USD
    0.39
    0.02 (5.63%)
    At close: Jun 09, 2025, 3:59 PM

    Applied Therapeutics Statistics

    Share Statistics

    Applied Therapeutics has 141.58M shares outstanding. The number of shares has increased by 1.83% in one year.

    Shares Outstanding

    n/a
    		 141.58M

    Shares Change (YoY)

    n/a
    		 1.83%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 117.55M

    Failed to Deliver (FTD) Shares

    n/a
    		 111,848

    FTD / Avg. Volume

    n/a
    		 5.03%

    Short Selling Information

    The latest short interest is 19.79M, so 13.98% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 19.79M

    Short % of Shares Out

    n/a
    		 13.98%

    Short % of Float

    n/a
    		 14.08%

    Short Ratio (days to cover)

    n/a
    		 10.23

    Valuation Ratios

    The PE ratio is -1.13 and the forward PE ratio is -0.9. Applied Therapeutics's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.13

    Forward PE

    n/a
    		 -0.9

    PS Ratio

    n/a
    		 262.57

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 2.1

    P/FCF Ratio

    n/a
    		 -1.42

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Applied Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 3.06

    Quick Ratio

    n/a
    		 3.06

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.03

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $13,000

    Profits Per Employee

    n/a
    		 $-3,017,828.57

    Employee Count

    n/a
    		 35

    Asset Turnover

    n/a
    		 0.01

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -92.08% in the last 52 weeks. The beta is 1.87, so Applied Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.87

    52-Week Price Change

    n/a
    		 -92.08%

    50-Day Moving Average

    n/a
    		 0.4

    200-Day Moving Average

    n/a
    		 3.2

    Relative Strength Index (RSI)

    n/a
    		 44.71

    Average Volume (20 Days)

    n/a
    		 2,222,098

    Income Statement

    In the last 12 months, Applied Therapeutics had revenue of 455K and earned -105.62M in profits. Earnings per share was -0.76.

    Revenue

    n/a
    		 455K

    Gross Profit

    n/a
    		 30K

    Operating Income

    n/a
    		 -104.3M

    Net Income

    n/a
    		 -105.62M

    EBITDA

    n/a
    		 -103.87M

    EBIT

    n/a
    		 -104.3M

    Earnings Per Share (EPS)

    n/a
    		 -0.76
    Full Income Statement

    Balance Sheet

    The company has 79.4M in cash and 2.79M in debt, giving a net cash position of 76.6M.

    Cash & Cash Equivalents

    n/a
    		 79.4M

    Total Debt

    n/a
    		 2.79M

    Net Cash

    n/a
    		 76.6M

    Retained Earnings

    n/a
    		 -574.21M

    Total Assets

    n/a
    		 56.91M

    Working Capital

    n/a
    		 36M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -84.31M and capital expenditures 0, giving a free cash flow of -84.31M.

    Operating Cash Flow

    n/a
    		 -84.31M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -84.31M

    FCF Per Share

    n/a
    		 -0.6
    Full Cash Flow Statement

    Margins

    Gross margin is 6.59%, with operating and profit margins of -22922.86% and -23214.07%.

    Gross Margin

    n/a
    		 6.59%

    Operating Margin

    n/a
    		 -22922.86%

    Pretax Margin

    n/a
    		 -23214.07%

    Profit Margin

    n/a
    		 -23214.07%

    EBITDA Margin

    n/a
    		 -22829.23%

    EBIT Margin

    n/a
    		 -22922.86%

    FCF Margin

    n/a
    		 -18528.57%

    Dividends & Yields

    APLT does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for APLT is $5, which is 1251.4% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $5

    Price Target Difference

    n/a
    		 1251.4%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -18.63

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist